1. Market Research
  2. > Pharmaceutical Market Trends
Preclinical Research Outsourcing Services: Global Markets

Preclinical Research Outsourcing Services: Global Markets

  • May 2022
  • 147 pages
  • ID: 6277482
  • Format: PDF
  • BCC Research

Summary

Table of Contents

Report Scope:
This report identifies the global preclinical research outsourcing services market, along with all major global preclinical CRO companies.The total preclinical research outsourcing services market is segmented globally and by geographic regions.

The service areas provided by preclinical CROs are extensively covered as well. The report offers a detailed examination of preclinical services, analyzes market trends for preclinical research outsourcing services with data from 2020, estimates from 2021, and projections of CAGR through 2026 (forecast period 2021–2026).

This report provides a comprehensive analysis of the top preclinical CROs and evolving roles in the preclinical outsourcing services.CRO expertise within certain therapeutic areas and experience with new and adaptive study design protocols can reduce costs and study duration.

CROs are expected to continue to play an increasing role in many aspects of the preclinical and clinical trial process.

Strong demand for CROs leads to heightened market assessments and many blockbuster mergers and acquisitions (M&As).M&A activity has led to a few companies to develop proficiency across many areas of the clinical trial process.

However, niche players still play crucial roles. This report analyzes emerging trends and changing dynamics within the preclinical research outsourcing services industry.

Report Includes:
- 24 data tables and 12 additional tables
- An up-to-date review and analysis of the global markets for preclinical research outsourcing services
- Analyses of the global market trends, with historic revenue (sales) data from 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation and forecast the global market size for preclinical research outsourcing services, projected growth trends, and corresponding market share analysis by functional services and geographic region
- In-depth information (facts and figures) concerning market drivers, market deterrents and other macroeconomic forces affecting the current and future market demand
- Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Regulatory structure for preclinical research studies in the pharmaceuticals industry, marketed and pipeline products, pricing and reimbursement structure, and major developments influencing the progress of this market
- Detailed analysis on the strength, weakness, and opportunities of the prominent players operating in the global preclinical research outsourcing services market
- Insight into recent industry structure, current competitive scenario, increasing investments on R&D activities, current pharma/CRO contracts and company value share analysis based on their segmental revenues
- Company profiles of major players, including Eurofins Scientific, IQVIA, Labcorp, SGS SA, and Thermo Fisher

Summary:
Outsourcing preclinical services of the drug discovery and development process offers the pharmaceutical industry a wide range of opportunities to develop and commercialize, innovative methods and technologies.Outsourcing is an attractive approach for investigations that are too complex, too expensive, and too lengthy otherwise to be conducted in-house.

In previous times, outsourcing was seen as a short-term strategy for demand realization. Now, it is
considered as the key lever for the core competencies to increase performance in pharmaceutical research. Outsourcing can positively impact research performance because it lowers the cost and time associated with new innovations.

There are two ways to outsource services -
- Full vertical integration, which maximizes operations conducted in-house.
- Virtual operations, which relates to full outsourcing and where all operations are methodically outsourced to third parties.

The outsourcing service providers/CROs market continues to exhibit significant growth, largely attributed to increased demand for services in clinical trials including preclinical research.The proliferation of therapies for orphan drugs and precision-based medicines, preclinical and clinical trials are becoming increasingly complex, which is driving demand for sophisticated outsourcing partners with expertise in preclinical services, disease registries, real world evidence, medical affairs and risk-based monitoring.

Expanding service offerings and capabilities remain a predominant strategy among CROs. The geographic distribution of clinical research is slowly shifting from developed nations to emerging
countries in regions such as Central and Eastern Europe, Asia-Pacific and Latin America. Also, the greater disease difference among developing countries offers more diverse population samples, particularly for rare disease studies.

IQVIA Inc., Labcorp PPD Inc., Syneos Health, Charles River Laboratories International Inc. and Medpace are the CRO industry’s dominant players. Mergers and acquisitions among these and other large companies in the preclinical research outsourcing continues at an extraordinary pace, driven by high valuations and the increasing need to become complete service providers. Current pharmaceutical R&D spending is driven by precision-based medicines and immunotherapies for smaller populations, genetic therapies for oncology, rare disease treatment and generally more demanding and complex protocols for drug development.

The preclinical research environment continues to be tied to exorbitant costs as complex therapies requiring larger and more diverse samples increases the time required and geographies involved in conducting a typical trials.To rein in costs and shorten development timelines, pharmaceutical and biopharma firms are increasingly outsourcing services to CROs.

In addition to complex therapies, combination regimens increase timelines and difficulties.Today, CROs operate more efficiently and improve quality and timeliness for sponsors despite the increasing complexities of studies.

This is bolstering CRO penetration in all stages of development.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Life Science Product Design & Development Service Market Research Report by Phase, End-user, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • $ 2949
  • July 2022
  • 139 pages

Life Science Product Design & Development Service Market Research Report by Phase (Concept & Requirements Development, Design Verification, and Detailed Design & Process Development), End-user, Application, ...

  • United States
  • Medical Device
  • Marketing Research
  • Industry analysis

ref:plp2022

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on